Previous Article | Next Article 
Journal of Virology, May 1999, p. 3603-3607, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human Follicular Dendritic Cells Remain Uninfected and Capture
Human Immunodeficiency Virus Type 1 through CD54-CD11a
Interaction
Masatoshi
Fujiwara,1
Rikiya
Tsunoda,2
Shiro
Shigeta,3
Tomoyuki
Yokota,1 and
Masanori
Baba4,*
Rational Drug Design Laboratories, Fukushima
960-1242,1 Department of Anatomy and
Histology2 and Department of
Microbiology,3 School of Medicine, Fukushima
Medical University, Fukushima 960-1247, and Division of
Human Retroviruses, Center for Chronic Viral Diseases, Faculty of
Medicine, Kagoshima University, Kagoshima
890-8520,4 Japan
Received 19 August 1998/Accepted 13 January 1999
 |
ABSTRACT |
It has been reported that human immunodeficiency virus type 1 (HIV-1) bound to follicular dendritic cells (FDCs) remains highly infectious to CD4+ T cells even when it forms immune
complexes with neutralizing antibody (HIV-1/IC). To elucidate
the role of FDCs in HIV-1 transmission to CD4+ T cells in
lymph nodes, we have isolated and purified FDCs from human tonsils and
examined whether the HIV-1/IC trapped on their surface is infectious to
CD4+ T cells. To our surprise, not the HIV-1/IC but the
antibody-free HIV-1 on FDCs could be transmitted to CD4+ T
cells. Furthermore, in contrast to previous studies showing that FDCs
are productively infected with HIV-1, the present study clearly
demonstrated that FDCs were not the target cells for HIV-1 infection. FDCs could capture the viral particles on their surface; however, the binding of HIV-1 to FDCs was strongly
inhibited by the presence of anti-CD54 (ICAM-1) monoclonal antibody
(MAb) and anti-CD11a (LFA-1) MAb, suggesting that the
adhesion molecules play an important role in the interaction between
HIV-1 and FDCs.
 |
INTRODUCTION |
The germinal centers play a key role
in producing memory B cells and plasma cells. The main constituents of
germinal center microenvironment are activated germinal-center B
cells (centroblasts and centrocytes), follicular dendritic cells
(FDCs), macrophages, CD4+ and CD8+ T
cells, and dendritic cells (6, 10, 12, 13, 16, 17, 26). FDCs
belong to so-called B-cell-associated dendritic cells with desmosomal
junctions (29), and they have two notable characteristics. First, FDCs have very intimate relationships with the germinal-center B
cells such as thymic nurse cells in vitro and in vivo (13, 15, 34,
36). Second, they are long-term antigen-presenting cells for the
germinal-center B cells (18, 19, 28). The latter function
seems important in pathological conditions such as with infectious diseases.
In human immunodeficiency virus type 1 (HIV-1) infection, FDCs not only
handle the viral antigens but also interact with infectious virions.
This is particularly relevant to the pathogenesis of this disease,
since the CD4+ T cells that migrated into the light zone of
the germinal centers can be infected with HIV-1 trapped on the surface
of the FDCs. The first evidence that the germinal centers were infected
with HIV-1 was provided by ultrastructural analysis for lymph
nodes obtained from infected patients (1). The virions
were located in the interdendritic extracellular spaces and embedded in
a moderately electron-dense material covering the surface of the FDCs.
This localization indicated that the capture of HIV-1 with
immunoglobulins by FDCs was responsible for the infection of the
germinal centers. Stahmer et al. reported that normal human tonsil FDCs
were highly susceptible to HIV-1 infection in a CD4-independent fashion
in vitro (25). Furthermore, the HIV-1-infected FDCs not only
contain proviral DNA but also produce viral particles and transmit them to CD4+ T cells (24). When HIV-1 formed immune
complexes with its neutralizing antibody (HIV-1/IC) and was trapped by
FDCs, the virus remained highly infectious to CD4+ T cells
(11). However, our previous study demonstrated that FDCs
themselves were not susceptible to HIV-1 infection (33). We
also found that more HIV-1 particles were trapped by fresh FDCs than by
dedifferentiated FDCs or control fibroblasts, yet the surface molecules
mediating this binding could not be determined. In the present study,
we have isolated and purified FDCs from human tonsils and examined the
infectivity of HIV-1 particles trapped on their surface. We have shown
that not the HIV-1/IC but the antibody-free HIV-1 on FDCs can be
transmitted to CD4+ T cells. Furthermore, the adhesion
molecules CD54 (ICAM-1) and CD11a (LFA-1) play an important role in the
interaction between HIV-1 particles and FDCs.
 |
MATERIALS AND METHODS |
Isolation and cultivation of FDCs.
FDCs were isolated and
purified from surgically resected fresh palatine tonsils, which were
kindly provided by M. Hattori (Fujita General Hospital, Fukushima,
Japan). The methods for enucleation and subsequent digestion of lymph
follicles have been previously described (31-33). Briefly,
more than 200 lymph follicles were enucleated from ca. 1-mm-thick
slices of tonsil under an anatomical microscope. The follicles were
then digested with an enzyme cocktail of collagenase A (0.5 mg/ml;
Boehringer Mannheim, Mannheim, Germany), dispase II (0.5 mg/ml;
Boehringer Mannheim) and DNase I (0.04 mg/ml; Boehringer Mannheim). FDC
clusters (FDCs engulfing several germinal-center lymphocytes)
(14) were then separated from the free cell suspension by
four repeated sedimentations. After final purification, the ratio of
FDC clusters to mixed free cells was approximately 97% (vol/vol). To
remove contaminating macrophages, the FDC cluster-enriched fraction was
cultured in plastic culture dishes with RPMI 1640 supplemented with
10% fetal calf serum (BioWhittaker, Walkersville, Md.) at 37°C for
60 min. The nonadherent population was transferred to other plastic
culture dishes (Corning Glass Works, Corning, N.Y.) and maintained
under the same conditions. After a 6-h incubation, the plastic wells
were washed with culture medium, and weakly adherent cells (FDC
clusters) were collected with a cell scraper. To eliminate possible
contamination with CD4+ T cells, the final FDC clusters
were further purified by negative selection with CD4 antibody-labeled
magnetic beads (Dynabeads M-450; Dynal A.S., Oslo, Norway).
Purification and stimulation of human CD4+ T
cells.
Autologous tonsillar lymphocytes were separated with
Lymphprep (Nyomed Pharma, Oslo, Norway) from fresh tonsillar cells. The CD4+ T-cell population was further purified by positive
selection with the above-mentioned CD4 antibody-labeled magnetic beads
and detached antibody. CD4+ T cells were activated by the
incubation with 100 pg of staphylococcal enterotoxin E (Toxin
Technology, Sarasota, Fla.) per ml.
HIV-1 exposure of FDCs and coculture with CD4+ T
cells.
HIV-1/IC were prepared by incubating 5,000 50% cell
culture infective doses per 100 µl of HIV-1 (IIIB strain)
at 37°C for 2 h with 100 µl of fresh serum obtained from
HIV-1-infected patients. FDCs were exposed to either HIV-1/IC or free
HIV-1 for 12 h at 4°C. The cells were then extensively washed to
remove untrapped virions and cocultured with CD4+ T cells
in fresh culture medium. After a 5-day incubation at 37°C, DNA was
isolated from the cells and stored at
20°C until use. The p24
antigen levels in culture supernatants were measured by a p24 antigen
capture enzyme-linked immunosorbent assay (ELISA) kit (Cellular
Products, Inc., Buffalo, N.Y.), according to the manufacturer's
instructions. In some experiments, the HIV-1-exposed FDCs were
cocultured with activated CD4+ T cells by using a cell
culture insert (0.4-µm diameter; Becton Dickinson, Franklin Lakes,
N.J.) to avoid cell-to-cell contact between FDCs and CD4+ T
cells. In the experiments with anti-adhesion molecule monoclonal antibodies (MAbs), FDCs were exposed to HIV-1 together with 10 µg of
anti-CD54, anti-CD11a, or anti-CD106 MAb per ml at 4°C for 12 h,
extensively washed, and incubated at 37°C for 5 days. The antibodies
were purchased from Becton Dickinson. The cells were cocultured with
activated CD4+ T cells in fresh culture medium for 4 days,
and the p24 antigen production and the proviral DNA synthesis were determined.
Detection of HIV-1 proviral DNA.
DNA was isolated from the
cells (106 cells) with a nucleic acid extraction kit
(IsoQuick; Orch Research, Bothell, Wash.). PCR analysis for HIV-1
gag and
-globin DNA was performed with the primer pairs
SK38/39 (20) and GH20/PC04 (3), respectively. The
PCR products were analyzed by electrophoresis (1.5% agarose), stained
with ethidium bromide for detection of
-globin DNA, and transferred
to Hybond-N+ membranes (Amersham, Buckinghamshire, United
Kingdom) for detection of HIV-1 gag DNA. The blot was
hybridized with the 32P-labeled oligonucleotide probe SK-19
(20). OM-10.1 cells (7), a chronically infected
clone harboring a single HIV-1 provirus, were used as a positive control.
TEM analysis.
FDCs were exposed to HIV-1/IC or HIV-1 at
4°C for 12 h in the absence or presence of anti-CD54 and
anti-CD11a MAbs. For transmission electron microscopy (TEM) analysis,
the FDCs were treated in a routine manner, including fixation in
ice-cold 2.5% glutaraldehyde buffered with 0.1 M phosphate solution
(pH 7.4) for 2 h, postfixation in 1% osmium tetroxides for 1 h, dehydration, embedding in Epon, ultrathin sectioning,
counterstaining, and observation by TEM (Jeol, Tokyo, Japan).
 |
RESULTS |
FDCs are not the target cells for HIV-1 but transmit the virus to
CD4+ T cells.
Heath et al. reported that FDCs could
convert the neutralized HIV-1 into an infectious form even in the
presence of a vast excess of neutralizing antibody (11).
Therefore, we first examined whether CD4+ T cells could be
infected with HIV-1/IC, which might be trapped by FDCs. Establishment
of infection was monitored by p24 antigen production in culture
supernatants and by proviral DNA synthesis in the cells. When purified
FDCs were exposed to HIV-1/IC for 12 h at 4°C, extensively
washed, and cocultured with activated CD4+ T cells for 5 days at 37°C, the levels of p24 antigen in the culture supernatants
were 0.16 and 0.10 ng/ml in experiments 1 and 2, respectively (Table
1). These values were only four- to fivefold higher than those in the FDC culture without CD4+
T cells (0.04 and 0.02 ng/ml, respectively).
The patient sera used in this assay seemed to efficiently
neutralize the infectivity of HIV-1 because a high level of
HIV-1 production (>1 ng/ml) was not observed in CD4+ T
cells simply exposed to HIV-1/IC without FDCs (Table 1). In order to
confirm their neutralizing activity and specificity, the
patients' sera, as well as HIV-1-negative human sera, were examined for the effects on HIV-1 infectivity in MT-4 cells (a T-lymphoblastoid cell line). The patients' sera but not the
HIV-1-negative sera could reduce the viral infectivity in
a dose-dependent fashion (data not shown). For instance, a
patient serum achieved >3.6, 2.5, and 1.4 log10 reductions
of the infectivity of the viral suspension when mixed at ratios
(vol/vol) of 1:1, 1:9, and 1:99, respectively. Furthermore, HIV-1
particles could be identified on the surface of FDCs, as determined by
TEM analysis (Fig. 1A). Twenty-eight
viral particles were observed on the surface of 54 FDCs (51.9%). These
results suggest that the reduced infectivity of HIV-1/IC is not due to
the lack of HIV-1/IC capture by FDCs. Thus, we could not confirm the
previous finding that FDCs converted the neutralized HIV-1 into an
infectious form in the presence of neutralizing antibody
(11). PCR and Southern blot analysis revealed that specific
amplified products (proviral DNA) were not detectable for all samples
extracted from the culture cells (Table 1), indicating that the
transmission of HIV-1/IC from FDCs to CD4+ T cells does not
commonly occur.

View larger version (144K):
[in this window]
[in a new window]
|
FIG. 1.
TEM for HIV-1/IC or HIV-1-exposed FDCs. An HIV-1/IC
particle (arrow in panel A) was observed on the surface of FDC
(×25,000). Twenty-eight viral particles were observed on the surface
of 54 FDCs (51.9%). Similarly, an antibody-free HIV-1 particle (arrow
in panel B) was captured on the top of a delicate cytoplasmic process
of FDCs (×10,000; inset, ×75,000). Twenty-seven particles were
observed on the surface of 55 FDCs (49.1%). Pleural virions (arrows in
panel C) were often observed among the extracellular spaces of fine
cytoplasmic processes of FDCs in isolated FDC-lymphocytes complex (FDC
cluster) (×8,000). In contrast, such virions were scarcely identified
on the surfaces of FDCs treated with a combination of anti-CD54 MAb and
anti-CD11a MAb (panel D). Only one particle was identified on the 64 FDCs (1.6%). Desmosomal junctions, which are a reliable morphological
marker of FDCs, were observed in panels B and D (arrowheads). These
pictures are representative electron micrographs of some FDCs analyzed
in this study.
|
|
We next examined the same experiments with antibody-free virions. In
contrast to the experiments with HIV-1/IC, the free HIV-1
retained a high degree of infectivity and, except for experiment
1, infection of the CD4
+ T cells with the virus brought
about a high level of p24 antigen
production (6.0 and 12.5 ng/ml in
experiments 2 and 3, respectively)
(Table
1). When FDCs were exposed to
the free virus and extensively
washed, the trapped HIV-1 was found to
be highly infectious. After
cocultivation with CD4
+ T
cells, the p24 levels in the culture supernatants ranged between
6.0 ng/ml (experiment 1) and 26.0 ng/ml (experiment 2). However,
it is
unlikely that FDCs produced such amounts of viral antigens,
and almost
all of the viral particles and antigens were considered
to be produced
by CD4
+ T cells after viral transmission from FDCs because
the p24 antigen
levels in the culture supernatant of FDCs alone were
extremely
low (undetectable levels to 0.07 ng/ml). Furthermore, the PCR
analysis showed that the proviral DNA was undetectable for the
samples
extracted from the FDCs alone after viral exposure (Table
1),
confirming that FDCs themselves are not the target cells
for HIV-1
replication. In addition, it is also clear that the
virions trapped on
the surface of FDCs (Fig.
1B and C) were highly
transmissible to the
susceptible
cells.
Cell-to-cell contact is necessary for HIV-1 transmission from FDCs
to CD4+ T cells.
To examine whether the transmission
of HIV-1 from FDCs to CD4+ T cells requires cell-to-cell
contact, HIV-1-exposed FDCs were separated from CD4+ T
cells in the same wells by using a filter with a 0.4-µm diameter (cell culture insert). Again, high levels of p24 antigen production were observed in two separate experiments when HIV-1-exposed FDCs and
CD4+ T cells were in contact with each other (Table
2). In contrast, much less amounts
(undetectable levels and 0.7 ng/ml) of the antigens were produced in
the culture supernatants when HIV-1-exposed FDCs and CD4+ T
cells were incubated without this contact. In these experiments, proviral DNA was detected for the cocultured cells but not for the
cells separately cultured (Table 2). These results indicate that
cell-to-cell contact is required for HIV-1 transmission from FDCs to
CD4+ T cells.
Adhesion molecules play a crucial role in HIV-1 binding to
FDCs.
Although it is clear that FDCs capture HIV-1 on their
surface, the molecular mechanism of their interaction is not yet fully understood. Therefore, we examined the influence of various
anti-adhesion molecule MAbs on the HIV-1 capture activity of FDCs. To
this end, FDCs were isolated and purified from the tonsils of several
donors and exposed to HIV-1 in the absence or presence of the MAbs.
After a 12-h incubation at 4°C, the cells were extensively washed to remove untrapped virions and cultured at 37°C for 5 days. Then the
cells were cocultured with CD4+ T cells. As shown in Fig.
2, the treatment with anti-CD54 MAb or
the combination of anti-CD54 MAb with anti-CD11a MAb significantly reduced the production of p24 antigens from cocultured CD4+
T cells. However, the treatment with anti-CD106 (VCAM-1) MAb did not
affect the p24 antigen production. These results suggest that anti-CD54
and anti-CD11a MAbs either block the entrapment of virions on the
surface of FDCs or interfere with the transmission of trapped virions
to cocultured CD4+ T cells. To distinguish between these
two possibilities, HIV-1-exposed FDCs in the absence or presence of the
MAbs were analyzed by TEM. HIV-1 particles were observed on the surface
of FDCs frequently (49.1% of total FDCs observed) when the cells were
not treated with the anti-CD54 and anti-CD11a MAbs (Fig. 1B and C). In
contrast, such particles were hardly (1.6%) identified on the surface
of FDCs that had been treated with the MAbs (Fig. 1D).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Inhibitory effects of anti-adhesion molecule MAbs on the
entrapment and infectivity of HIV-1 in FDC cultures. FDCs were isolated
and purified from human tonsils and exposed to HIV-1 at 4°C for
12 h in the absence (a) or in the presence of anti-CD54 (ICAM-1)
MAb (b), anti-CD11a (LFA-1) MAb (c), anti-CD54 MAb plus anti-CD11a MAb
(d), or anti-CD106 (VCAM-1) MAb (e). The cells were extensively washed
and incubated at 37°C. After a 5-day incubation, FDCs were cocultured
with activated CD4+ T cells in fresh culture medium for 4 days. The p24 antigen levels were determined by antigen capture ELISA
and expressed as a percentage of the control culture (a). The mean
values in each group are indicated by horizontal bars, and the
statistical significance was analyzed by the t test.
|
|
 |
DISCUSSION |
Initial studies on HIV-1 pathogenesis in lymph nodes have revealed
a novel and surprising finding that FDCs are responsible for the
infection of germinal centers. FDCs are peculiar dendritic cells that
carry immune complexes on their surfaces (18, 35). Health et
al. reported that, once HIV-1 was trapped by FDCs, the virus became
highly infectious to CD4+ T cells even in the presence of
antibodies that would otherwise neutralize it (11). However,
we demonstrated that FDCs could not transmit HIV-1/IC to
CD4+ T cells, though FDCs could capture HIV-1/IC on their
surface (Table 1 and Fig. 1A). The reason for this discrepancy may be due to the differences in neutralizing antibodies used in our experiments. We speculate that, in the earlier experiments, the formation of HIV-1/IC might have been incomplete and therefore the
antibody-free particles were also trapped on the surface of FDCs
together with HIV-1/IC. In our study, we repeated the experiment with
FDCs from different donors and with sera from different patients, yet a
reproducible result was obtained (Table 1). Furthermore, HIV-1/IC was
found to be much less infectious to CD4+ T cells than was
the free HIV-1 and, even when trapped, FDCs could not convert the virus
into its infectious form.
Another important finding in this study is that FDCs themselves were
not susceptible to HIV-1 infection, irrespective of the viral forms
(immune complex or free) and did not produce the viral antigens during
at least a 5-day culture period (Table 1). Previous studies in
immunohistochemistry and electron microscopy demonstrated that FDCs
play an important role in the pathogenesis of AIDS, serving as a major
reservoir of HIV-1 (1, 23, 27). Our electron microscopic
observations also indicated that the trapped virions were
morphologically intact. Thus, FDCs appear to be sequentially supplied
with infectious virions and to function as a viral reservoir, where the
virus remains infectious to CD4+ T cells for several days.
Although the molecular mechanism involved in the entrapment of HIV-1 by
FDCs is of particular importance, it has not been elucidated yet.
Blauvelt et al. reported that the productive infection of
T-cell-associated dendritic cells with HIV-1 and their ability to
capture the virus were mediated through separate machineries. The
former was dependent on the CD4 molecule and HIV-1 coreceptors, while
the latter was not (4). FDCs do not express CD4 and the coreceptors on their surface (5, 22, 37), suggesting that FDCs use other mechanisms for the capture HIV-1 particles. We previously reported that the infectivity of FDC-trapped HIV-1 was lost
during a 25-day incubation period (33). The expression of
adhesion and costimulatory molecules on FDCs were rapidly downregulated in vitro, and the amount of expressed CD54 after a 35-day incubation was less than one-hundredth of that after a 7-day incubation
(32). Furthermore, the interaction between the
virus-incorporated and the host cellular adhesion molecules CD54 and
CD11a is known to markedly enhance the capacity of HIV-1 for its
binding and entry into CD4+ T cells (2, 8, 9, 21,
30). These findings and our present observations strongly suggest
the use of CD54 and CD11a in the FDC capture of HIV-1 particles.
In conclusion, we have demonstrated that (i) FDCs are able to capture
HIV-1 on their surfaces in vitro, (ii) that the FDC-trapped virions
remain infectious and are transmitted to cocultured CD4+ T
cells but (iii) that the FDCs themselves are not susceptible to these
virions, and (iv) that the adhesion molecules expressed on FDCs and the
viral envelope play an important role in the interaction between FDCs
and HIV-1. Further studies are required to elucidate the complete
functions of the FDCs in the pathogenesis of HIV-1 infection.
 |
ACKNOWLEDGMENTS |
M.F. and R.T. contributed equally to this work.
OM-10.1 cells were obtained through the AIDS Research and Reference
Reagent Program, National Institute of Allergy and Infectious Diseases,
Bethesda, Md. (the contributor was S. Butera).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Human Retroviruses, Center for Chronic Viral Diseases, Faculty of
Medicine, Kagoshima University, 8-35-1, Sakuragaoka, Kagoshima
890-8520, Japan. Phone: 81-99-275-5930. Fax: 81-99-275-5932. E-mail: baba{at}med3.kufm.kagoshima-u.ac.jp.
 |
REFERENCES |
| 1.
|
Armstrong, J. A., and R. Horne.
1984.
Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy.
Lancet
ii:370-372.
|
| 2.
|
Bastiani, L.,
S. Laal,
M. Kim, and S. Zolla-Pazner.
1997.
Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions.
J. Virol.
71:3444-3450[Abstract].
|
| 3.
|
Bauer, H. M.,
Y. Ting,
C. E. Greer,
J. C. Chambers,
C. J. Tashiro,
J. Chimera,
A. Reingold, and M. M. Manos.
1991.
Genital human papillomavirus infection in female university students as determined by a PCR-based method.
JAMA
265:472-477[Abstract/Free Full Text].
|
| 4.
|
Blauvelt, A.,
H. Asada,
N. W. Saville,
V. Klaus-Kovtun,
D. J. Altman,
R. Yarchoan, and S. I. Katz.
1997.
Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.
J. Clin. Invest.
100:2043-2053[Medline].
|
| 5.
|
Butch, A. W.,
G.-H. Chung,
J. W. Hoffmann, and M. H. Nahm.
1993.
Cytokine expression by germinal center cells.
J. Immunol.
150:39-47[Abstract].
|
| 6.
|
Butcher, E. C.,
R. V. Rouse,
R. L. Coffman,
C. N. Nottenburg,
R. R. Hardy, and I. L. Weissman.
1982.
Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation.
J. Immunol.
129:2698-2707[Abstract].
|
| 7.
|
Butera, S. T.,
P. L. Perez,
B.-Y. Wu,
G. J. Nabel, and T. M. Folks.
1991.
Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.
J. Virol.
65:4645-4653[Abstract/Free Full Text].
|
| 8.
|
Fortin, J.-F.,
R. Cantin,
G. Lamontagne, and M. J. Tremblay.
1997.
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.
J. Virol.
71:3588-3596[Abstract].
|
| 9.
|
Fortin, J.-F.,
R. Cantin, and M. J. Tremblay.
1998.
T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.
J. Virol.
72:2105-2112[Abstract/Free Full Text].
|
| 10.
|
Grouard, G.,
I. Durand,
L. Filgueira,
J. Banchereau, and Y. J. Liu.
1996.
Dendritic cells capable of stimulating T cells in germinal centres.
Nature
384:364-367[Medline].
|
| 11.
|
Heath, S. L.,
J. G. Tew,
A. K. Szakal, and G. F. Burton.
1995.
Follicular dendritic cells and human immunodeficiency virus infectivity.
Nature
377:740-744[Medline].
|
| 12.
|
Heinen, E.,
N. Cormann, and C. Kinet-Denoël.
1988.
The lymph follicle: a hard nut to crack.
Immunol. Today
9:240-243[Medline].
|
| 13.
|
Imai, Y., and M. Yamakawa.
1996.
Morphology, function and pathology of follicular dendritic cells.
Pathol. Int.
46:807-833[Medline].
|
| 14.
|
Lilet-Leclercq, C.,
D. Radoux,
E. Heinen,
C. Kinet-Denoel,
J. O. Defraigne,
M. P. Houben-Defresne, and L. J. Simar.
1984.
Isolation of follicular dendritic cells from human tonsils and adenoids. I. Procedure and morphological characterization.
J. Immunol. Methods
66:235-244[Medline].
|
| 15.
|
Lindhout, E.,
A. Lakeman, and C. de Groot.
1995.
Follicular dendritic cells inhibit apoptosis in human B lymphocytes by a rapid and irreversible blockade of preexisting endonuclease.
J. Exp. Med.
181:1985-1995[Abstract/Free Full Text].
|
| 16.
|
Liu, Y. J.,
G. D. Johnson,
J. Gordon, and I. C. MacLennan.
1992.
Germinal centers in T-cell-dependent antibody responses.
Immunol. Today
13:17-21[Medline].
|
| 17.
|
MacLennan, I. C., and D. Gray.
1986.
Antigen-driven selection of virgin and memory B cells.
Immunol. Rev.
91:61-85[Medline].
|
| 18.
|
Nossal, G. J. V.
1994.
Differentiation of the secondary B-lymphocyte repertoire: The germinal center reaction.
Immunol. Rev.
137:173-183[Medline].
|
| 19.
|
Nossal, G. J. V.,
A. Abbott,
J. Mitchell, and Z. Lummus.
1968.
Antigens in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles.
J. Exp. Med.
127:277-290[Abstract].
|
| 20.
|
Ou, C.-Y.,
S. Kwok,
S. W. Mitchell,
D. H. Mack,
J. J. Sninsky,
J. W. Krebs,
P. Feorino,
D. Warfield, and G. Schochetman.
1988.
DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.
Science
239:295-297[Abstract/Free Full Text].
|
| 21.
|
Rizzuto, C. D., and J. G. Sodroski.
1997.
Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization.
J. Virol.
71:4847-4851[Abstract].
|
| 22.
|
Schriever, F.,
A. S. Freedman,
G. Freeman,
E. Messner,
G. Lee,
J. Daley, and L. M. Nadler.
1989.
Isolated human follicular dendritic cells display a unique antigenic phenotype.
J. Exp. Med.
169:2043-2058[Abstract/Free Full Text].
|
| 23.
|
Spiegel, H.,
H. Herbst,
G. Niedobitek,
H.-D. Foss, and H. Stein.
1992.
Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells.
Am. J. Pathol.
140:15-22[Abstract].
|
| 24.
|
Sprenger, R.,
K.-M. Toellner,
C. Schmetz,
W. Lüke,
C. Stahl-Henning,
M. Ernst,
G. Hunsmann,
H. Schmitz,
H.-D. Flad,
J. Gerdes, and J. P. Zimmer.
1995.
Follicular dendritic cells productively infected with immunodeficiency viruses transmit infection to T cells.
Med. Microbiol. Immunol.
184:129-134[Medline].
|
| 25.
|
Stahmer, I.,
J. P. Zimmer,
M. Ernst,
T. Fenner,
R. Finnern,
H. Schmitz,
H.-D. Flad, and J. Gerdes.
1991.
Isolation of normal human follicular dendritic cells and CD4-independent in vitro infection by human immunodeficiency virus (HIV-1).
Eur. J. Immunol.
21:1873-1878[Medline].
|
| 26.
|
Stein, H.,
J. Gerdes, and D. Y. Mason.
1982.
The normal and malignant germinal centre.
Clin. Haematol.
11:531-559[Medline].
|
| 27.
|
Tenner-Rácz, K.,
P. Rácz,
M. Dietrich, and P. Kern.
1985.
Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy.
Lancet
i:105-106.
|
| 28.
|
Tew, J. G.,
T. E. Mandel, and A. W. Burgess.
1979.
Retention of intact HSA for prolonged periods in the popliteal lymph nodes of specifically immunized mice.
Cell. Immunol.
45:207-212[Medline].
|
| 29.
|
Tew, J. G.,
G. J. Thorbecke, and R. M. Steinman.
1982.
Dendritic cells in the immune response: characteristic and recommended nomenclature (a report from the Reticuloendothelial Society Committee on nomenclature).
J. Reticuloendothel. Soc.
31:371-380[Medline].
|
| 30.
|
Tremblay, M. J.,
J. F. Fortin, and R. Cantin.
1998.
The acquisition of host-encoded proteins by nascent HIV-1.
Immunol. Today
19:346-351[Medline].
|
| 31.
|
Tsunoda, R.
1995.
Long-term cultivation of human follicular dendritic cells, p. 111-124.
In
E. Heinen (ed.), Follicular dendritic cells in normal and pathological conditions. R. G. Landes Co., Austin, Tex.
|
| 32.
|
Tsunoda, R.,
A. Bosseloir,
K. Onozaki,
E. Heinen,
K. Miyake,
H. Okamura,
K. Suzuki,
T. Fujita,
L. J. Simar, and N. Sugai.
1997.
Human follicular dendritic cells in vitro and follicular dendritic-cell-like cells.
Cell Tissue Res.
288:381-389[Medline].
|
| 33.
|
Tsunoda, R.,
K. Hashimoto,
M. Baba,
S. Shigeta, and N. Sugai.
1996.
Follicular dendritic cells in vitro are not susceptible to infection by HIV-1.
AIDS
10:595-602[Medline].
|
| 34.
|
Tsunoda, R.,
M. Nakayama,
E. Heinen,
K. Miyake,
K. Suzuki,
N. Sugai, and M. Kojima.
1992.
Emperipolesis of lymphoid cells by human follicular dendritic cells in vitro.
Virchows Arch. B Cell Pathol.
62:69-78[Medline].
|
| 35.
|
Van Rooijen, N.
1993.
The role of the FDC-retained immune complex network and its dynamics in the activity of germinal centres.
Res. Immunol.
144:545-552[Medline].
|
| 36.
|
Wekerle, H., and U.-P. Ketelsen.
1980.
Thymic nurse cells. Ia-bearing epithelium involved in T-lymphocyte differentiation?
Nature
283:402-404[Medline].
|
| 37.
|
Zhang, L.,
T. He,
A. Talal,
G. Wang,
S. S. Frankel, and D. D. Ho.
1998.
In vitro distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.
J. Virol.
72:5035-5045[Abstract/Free Full Text].
|
Journal of Virology, May 1999, p. 3603-3607, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gilbert, C., Cantin, R., Barat, C., Tremblay, M. J.
(2007). Human Immunodeficiency Virus Type 1 Replication in Dendritic Cell-T-Cell Cocultures Is Increased upon Incorporation of Host LFA-1 due to Higher Levels of Virus Production in Immature Dendritic Cells. J. Virol.
81: 7672-7682
[Abstract]
[Full Text]
-
Sigurdson, C. J., Barillas-Mury, C., Miller, M. W., Oesch, B., van Keulen, L. J. M., Langeveld, J. P. M., Hoover, E. A.
(2002). PrPCWD lymphoid cell targets in early and advanced chronic wasting disease of mule deer. J. Gen. Virol.
83: 2617-2628
[Abstract]
[Full Text]
-
Sanders, R. W., de Jong, E. C., Baldwin, C. E., Schuitemaker, J. H. N., Kapsenberg, M. L., Berkhout, B.
(2002). Differential Transmission of Human Immunodeficiency Virus Type 1 by Distinct Subsets of Effector Dendritic Cells. J. Virol.
76: 7812-7821
[Abstract]
[Full Text]
-
Smith-Franklin, B. A., Keele, B. F., Tew, J. G., Gartner, S., Szakal, A. K., Estes, J. D., Thacker, T. C., Burton, G. F.
(2002). Follicular Dendritic Cells and the Persistence of HIV Infectivity: The Role of Antibodies and Fc{gamma} Receptors. J. Immunol.
168: 2408-2414
[Abstract]
[Full Text]
-
Bounou, S., Leclerc, J. E., Tremblay, M. J.
(2002). Presence of Host ICAM-1 in Laboratory and Clinical Strains of Human Immunodeficiency Virus Type 1 Increases Virus Infectivity and CD4+-T-Cell Depletion in Human Lymphoid Tissue, a Major Site of Replication In Vivo. J. Virol.
76: 1004-1014
[Abstract]
[Full Text]
-
Turville, S. G., Arthos, J., Mac Donald, K., Lynch, G., Naif, H., Clark, G., Hart, D., Cunningham, A. L.
(2001). HIV gp120 receptors on human dendritic cells. Blood
98: 2482-2488
[Abstract]
[Full Text]
-
Smith, B. A., Gartner, S., Liu, Y., Perelson, A. S., Stilianakis, N. I., Keele, B. F., Kerkering, T. M., Ferreira-Gonzalez, A., Szakal, A. K., Tew, J. G., Burton, G. F.
(2001). Persistence of Infectious HIV on Follicular Dendritic Cells. J. Immunol.
166: 690-696
[Abstract]
[Full Text]
-
Olinger, G. G., Saifuddin, M., Spear, G. T.
(2000). CD4-Negative Cells Bind Human Immunodeficiency Virus Type 1 and Efficiently Transfer Virus to T Cells. J. Virol.
74: 8550-8557
[Abstract]
[Full Text]
-
Wahl, S. M., Greenwell-Wild, T., Hale-Donze, H., Moutsopoulos, N., Orenstein, J. M.
(2000). Permissive factors for HIV-1 infection of macrophages. J. Leukoc. Biol.
68: 303-310
[Abstract]
[Full Text]
-
Kacani, L., Prodinger, W. M., Sprinzl, G. M., Schwendinger, M. G., Spruth, M., Stoiber, H., Döpper, S., Steinhuber, S., Steindl, F., Dierich, M. P.
(2000). Detachment of Human Immunodeficiency Virus Type 1 from Germinal Centers by Blocking Complement Receptor Type 2. J. Virol.
74: 7997-8002
[Abstract]
[Full Text]
-
Kuster, H., Opravil, M., Ott, P., Schlaepfer, E., Fischer, M., Gunthard, H. F., Luthy, R., Weber, R., Cone, R. W.
(2000). Treatment-Induced Decline of Human Immunodeficiency Virus-1 p24 and HIV-1 RNA in Lymphoid Tissue of Patients with Early Human Immunodeficiency Virus-1 Infection. Am. J. Pathol.
156: 1973-1986
[Abstract]
[Full Text]
-
Jakubik, J. J., Saifuddin, M., Takefman, D. M., Spear, G. T.
(2000). Immune Complexes Containing Human Immunodeficiency Virus Type 1 Primary Isolates Bind to Lymphoid Tissue B Lymphocytes and Are Infectious for T Lymphocytes. J. Virol.
74: 552-555
[Abstract]
[Full Text]
-
Bounou, S., Dumais, N., Tremblay, M. J.
(2001). Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-kappa B- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription. J. Biol. Chem.
276: 6359-6369
[Abstract]
[Full Text]